Overview
The common assumption is that anyone who cannot absorb B12 properly must have injections. That turns out not to be right, and the reason is a piece of physiology worth knowing.
B12 is absorbed by two pathways. The main one is active and requires intrinsic factor, a protein made in the stomach — this is the pathway that fails in pernicious anemia and after gastric surgery. The second is passive diffusion, which requires no intrinsic factor at all. It is very inefficient, absorbing roughly one percent of what is presented.
One percent of a small amount is nothing. One percent of a large amount is enough — which is why high-dose oral B12 works even in people whose active pathway has failed, and why trials comparing high-dose oral against injections have generally found them comparably effective for correcting deficiency.
| High-dose oral | Injection | |
|---|---|---|
| Needs intrinsic factor? | No — passive diffusion does not | No |
| Works in pernicious anemia? | Yes, at high oral doses | Yes |
| Speed of initial correction | Slightly slower | Faster |
| Severe neurological symptoms | Not the usual first choice | Preferred initially |
| Depends on adherence | Yes — daily | No — periodic |
| Convenience | At home | Clinic visit or self-administration |
| Cost | Low | Higher |
Where injections still clearly win: severe deficiency with neurological symptoms, where speed matters and the consequences of under-treatment are lasting; situations where reliable daily adherence is genuinely doubtful; and some malabsorption states. Outside those, the route is largely a practical choice rather than a clinical one.
The two-pathway explanation
Worth understanding once, because it explains the whole comparison.
The active pathway. B12 in food is bound to protein. Stomach acid releases it, it binds to intrinsic factor produced by parietal cells in the stomach lining, and that complex is absorbed by a specific receptor in the terminal ileum. This pathway is efficient, and it is saturable — it handles only a limited amount at a time.
This is the pathway that fails in pernicious anemia (autoimmune destruction of parietal cells), after gastric surgery, and where the terminal ileum is diseased or removed.
The passive pathway. Separately, a small fraction of B12 crosses the intestinal wall by simple diffusion — no intrinsic factor, no receptor, no active transport. It absorbs roughly one percent of what is available.
That inefficiency is irrelevant if the amount presented is large enough. This is the mechanism that makes high-dose oral supplementation work in people whose active pathway is gone, and it is the finding that changed the guidance in much of the world.
What the comparative evidence shows
This has been studied directly, which is more than can be said for many route comparisons.
Randomized trials and systematic reviews comparing high-dose oral B12 against intramuscular injection have generally found them comparably effective for correcting deficiency and normalizing blood markers — including in patients with pernicious anemia and other malabsorption causes.
The practical consequence, adopted in a number of health systems, is that oral treatment is a reasonable first-line option for most people with B12 deficiency, with injections reserved for specific situations.
Two honest qualifications. Some of the trials are small. And the comparisons focus on correcting blood markers, with less data on neurological outcomes specifically — which is part of why injections remain preferred where neurological symptoms are significant.
When injections are the right choice
Severe deficiency with neurological involvement. Numbness, tingling, unsteadiness or cognitive symptoms. Here the speed of correction matters, because nerve damage present for long enough may not fully reverse. Injections are typically used at least initially, with a switch to oral considered later.
Doubtful adherence. Oral treatment depends entirely on taking it daily, indefinitely, in many cases for life. Where that is genuinely unlikely, a periodic injection is more reliable than a tablet not taken.
Some malabsorption states, including extensive small bowel disease or resection, where even passive absorption may be compromised.
Where oral has been tried and levels have not responded, which is a straightforward reason to change route.
The other B12 questions people ask
Which form? Cyanocobalamin and hydroxocobalamin are the standard forms and both are well established. Methylcobalamin and adenosylcobalamin are marketed as superior "active" forms; the practical evidence that this matters for correcting deficiency is limited. Hydroxocobalamin has a longer duration of action, which is why it is the injection form used in some countries.
Sublingual and nasal preparations exist. Sublingual absorption appears broadly comparable to oral, which is unsurprising given that passive diffusion is doing the work either way.
How long for? That depends on the cause. Pernicious anemia and surgical causes require lifelong treatment. Dietary or medication-related deficiency may be correctable, particularly if the medication can be reviewed.
Can you take too much? B12 is water-soluble and excess is excreted, and no upper limit has been established. High doses are generally regarded as safe, which is what makes the high-dose oral approach viable.
Why the cause still matters more than the route
Whichever route is used, the more important question is why the B12 was low.
Pernicious anemia is an autoimmune condition, needs lifelong treatment, and is associated with other autoimmune conditions including thyroid disease — worth knowing about rather than just correcting.
Long-term acid suppression or metformin may be reviewable.
Malabsorption points to something worth investigating.
Dietary cause is straightforward but worth confirming rather than assuming.
Treating the number without asking why is the most common shortcut in this area, and it leaves the actual condition in place. Why a normal panel does not close the question.
Frequently asked questions
Are B12 tablets as good as injections? For most causes, high-dose oral B12 has been found comparably effective in trials, including in pernicious anemia, because passive diffusion does not require intrinsic factor. Injections remain preferred for severe deficiency with neurological symptoms.
How can tablets work if I cannot absorb B12? A second, passive absorption pathway does not need intrinsic factor. It absorbs only about one percent — but one percent of a high dose is sufficient.
Do I need injections for pernicious anemia? Not necessarily. High-dose oral treatment has been shown to work in pernicious anemia, though injections are often used initially and where neurological symptoms are present.
Which form of B12 is best? Cyanocobalamin and hydroxocobalamin are the standard, well-established forms. Claims for methylcobalamin's superiority are not well supported for correcting deficiency.
How long will I need it? Depends on the cause. Pernicious anemia and surgical causes generally mean lifelong treatment; dietary or medication-related causes may be correctable.
Where this fits in your plan
The route question has a clearer answer than most people expect, and for many causes it comes down to convenience, adherence and cost rather than clinical necessity.
What is worth more attention is the diagnosis behind it — a low B12 has a cause, and identifying it changes how long you need treatment and what else should be checked. What we look at.
We measure first. Then we act.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
Ready to start your second act?
It starts with measuring, not guessing. A short, clinician-reviewed assessment shows what fits you.
This article is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.
